An Open Label Trial of Safety and Efficacy of Combination Therapy With Interferon beta-1a and Oral Doxycycline in Patients With Relapsing-Remitting Multiple Sclerosis.

Trial Profile

An Open Label Trial of Safety and Efficacy of Combination Therapy With Interferon beta-1a and Oral Doxycycline in Patients With Relapsing-Remitting Multiple Sclerosis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Jun 2015

At a glance

  • Drugs Doxycycline; Interferon beta-1a
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Mar 2011 Actual end date changed from Aug 2009 to Oct 2009 as reported by ClinicalTrials.gov.
    • 01 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top